Connection

Gregory Sempowski to Spike Glycoprotein, Coronavirus

Back to Details
This is a "connection" page, showing publications Gregory Sempowski has written about Spike Glycoprotein, Coronavirus.
Gregory Sempowski
Connection Strength
0.104
Spike Glycoprotein, Coronavirus
  1. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021 08 05; 184(16):4203-4219.e32.
    View in: PubMed
    Score: 0.026
  2. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. Cell. 2021 05 27; 184(11):2955-2972.e25.
    View in: PubMed
    Score: 0.026
  3. Cold sensitivity of the SARS-CoV-2 spike ectodomain. Nat Struct Mol Biol. 2021 02; 28(2):128-131.
    View in: PubMed
    Score: 0.026
  4. SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment. Annu Rev Med. 2022 01 27; 73:1-16.
    View in: PubMed
    Score: 0.007
  5. Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test. Sci Adv. 2021 06; 7(26).
    View in: PubMed
    Score: 0.007
  6. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature. 2021 06; 594(7864):553-559.
    View in: PubMed
    Score: 0.007
  7. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. Immunity. 2020 10 13; 53(4):724-732.e7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.